Correlation of SOZO BIS Measures With CardioMEMS PA Pressure
Completed
Conditions studied: NYHA Class III Heart Failure
In brief
This study aims to establish the degree to which change in the ratio of ECF to TBW measured using the SOZO BIS device correlates with change in end-expiratory end-diastolic PAP measured using the CardioMEMS HF System (St. Jude Medical).
Key facts
- Study ID
- NCT02939053
- Run by
- ImpediMed Limited
- People needed
- 3
- Starts
- 2017-08-29
- Expected to finish
- 2019-06-25
- Last updated by the study team
- 2019-07-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 years or older.
- NYHA Class III HF.
- Patient has undergone implantation of CardioMEMS HF System (St. Jude Medical).
- Patient is characterized by at least one of the following:
- CardioMEMS implanted within the previous 90 days
- Received treatment with intravenous diuretics within the previous 30 days
- Received dose escalation of oral diuretics at least twice within the previous 30 days
- Patient is able to sit upright for BIS measurements.
- Patient provides written informed consent and authorization to use and disclose health information.
You may not qualify if…
- Patient is enrolled in a concurrent interventional study of an experimental treatment that may confound the results of this study, in the investigator's opinion.
- Patient has a clinical condition that would not allow them to complete the study.
- Patient is pregnant or lactating.
- Patient has nephrotic syndrome or nephrosis.
- Patient has estimated glomerular filtration rate (eGFR) < 20 ml/min/1.73m2 or end-stage renal disease requiring chronic dialysis.
- Patient has been diagnosed with lymphedema.
- Patient has chronic liver failure or cirrhosis.
- Patient has a moderate or large pleural effusion as seen on chest X-ray.
- Patient has been diagnosed with thrombophlebitis or deep vein thrombosis in arms or legs in the past 90 days.
- Patient has an implanted cardiac rhythm management device (pacemaker or implantable cardioverter defibrillator).
- Patient has an amputation of a limb.
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
- Lancaster General Hospital — Lancaster, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.